Automated CPR Devices Market Size to Exceed USD 340.9 Mn by 2032

The Automated CPR Devices Market, estimated at USD 159.1 Mn in 2025, is expected to exhibit a CAGR of 11.5% and reach USD 340.9 Mn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

The high prevalence of geriatric population and increasing cardiovascular diseases is expected to dominate the global automated CPR devices market over the forecast period. For instance, in

January 2022, according to the American Heart Association, there are more than 356,000 out-of-hospital cardiac arrests (OHCA) annually in the U.S., nearly 90% of them fatal. The incidence of (Emergency medical service) EMS-assessed non-traumatic OHCA in people of any age is estimated to be 356,461, or nearly 1,000 people each day. Survival to hospital discharge after EMS-treated cardiac arrest languishes at about 10%.

Global Automated CPR Devices Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), that first appeared in Wuhan (province of Hubei, China), in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

The COVID-19 affected the economy in three main ways:  by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems regarding transportation of drugs from one place to another.

The COVID-19 had a positive impact on the global automated CPR devices market. During the Covid-19 outbreak, automatic CPR devices were in in demand. COVID-19-infected heart patients were more likely to have a cardiac arrest than non-infected ones. Patients were at a higher risk of cardiac arrest due to the virus's rapid mutation. Automatic CPR devices were critical in minimizing viral transmission while providing excellent and required treatments to patients. For instance, in February 2022, according to the Indian Journal of Anaesthesia, CPR in suspected or confirmed COVID-19 patients’ needs a modified approach compared to the conventional CPR technique. Several official bodies and organizations have published its guidelines and protocols for basic and advanced cardiac life support in COVID-19 patients. Notable amongst these are the ones issued by the European Resuscitation Council (ERC), the American Heart Association, the International Liaison Committee on Resuscitation, the Indian Society of Critical Medicine, and the Indian Resuscitation Council (IRC).

Global Automated CPR Devices Market: Key Developments

On April 30 2023, PathFree Technologies Corporation, a medical device manufacturer, announced the imminent release of the AiCart. The PathFree AiCart is a groundbreaking medical device that transforms cardiopulmonary resuscitation (CPR) and advanced cardiac life support (ACLS) procedures. By integrating artificial intelligence, this smart code cart streamlines the process, minimizes human error, and empowers medical response teams to save lives more efficiently. In this blog post, we'll explore the key features and benefits of the PathFree AiCart.

In May 2021, Canadian Pacific (CP) a privately owned company that operates one of Canada's two transcontinental railroad systems donated US$ 18,000 to the CK Hui Heart Centre for the purchase of a new LUCAS automated chest compression device. The device performs consistent, effective CPR which assists COVID-19 patients, reduces risks for care providers, and removes delays.

In July 2020, the Burgess Foundation provided a LUCAS device for the Emergency Department, a LUCAS Device is a chest compression system that helps patients that are in cardiac arrest. The device provides CPR delivery to a patient with vector more consistent quality depth and rate with fewer interruptions. It also can provide greater blood flow to the brain and heart with a higher chance of the return of spontaneous circulation.

Browse 32 Market Data Tables and 23 Figures spread through 208 Pages and in-depth TOC on “Global Automated CPR Devices Market, By Product Type (Load-Distributing Band (LDB) Devices, Piston CPR Devices, Active Compression-Decompression (ACD) Devices, Impedance Threshold Device, Extracorporeal Techniques & Invasive Perfusion Devices, Phased Thoracic-abdominal Compression-decompression CPR with a Handheld Device, and Others), By Compressor (Automatic Mechanical CPR, Battery Driven, Pneumatic Driven, Mechanically Actuated & Battery Driven, and Manual CPR), By End User (Hospitals, Ambulatory Surgical Centers, Ambulance and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)”

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/automated-cpr-devices-market-3865

Key Takeaways of the Global Automated CPR Devices Market:

• Global automated CPR devices market is expected to exhibit a CAGR of 11.5% during the forecast period, owing to increasing prevalence of cardiovascular diseases and geriatric population. For instance, in June 2021, According to the Centers for Disease Control and Prevention (CDC), cardiac illnesses claim the lives of more than 655,000 propel in U.S in a single year.
• Among Product, extracorporeal techniques & invasive perfusion devices segment is expected to be the dominant region in the global automated CPR devices market, owing to increasing prevalence of cardiovascular diseases, which is expected to propel the market growth. For instance, in August 2020, according to an article published in the Journal of Emerging Technologies for Heart Diseases, improvements in medical therapy and coronary revascularization have led to an increased survival rate in patients with coronary artery disease (CAD), with a consequent growing number of patients with severe and diffuse CAD which is not amenable to further revascularization procedures.
• Among Compressor, the battery driven segment is expected to dominate the global automated CPR market over the forecast period owing to the increase cardiovascular diseases. For instance, in September 2021, according to an article published in the Journal of Natures Review Cardiology, Deaths from Cardiovascular Diseases (CVD) in those aged less than 70 years, commonly referred to as premature with more than 60 million potential years of life lost to CVD in Europe annually. Although more women than men die from CVD, age-standardized rates of both morbidity and death are higher in men, and these differences in rates are greatest in individuals aged less than 70 years.
• Among End User, the hospitals segment is expected to dominate the market over the forecast period and this is attributed to the increasing prevalence of cardiovascular diseases. For instance, in February 2023, according to an article published in the Journal of Lancet Regional Health–Western Pacific, the Covid-19 outbreak led to the admissions for the severe cardiovascular diseases complications caused during Covid-19, where the hospital admission increases begin in 2020.
• Major players operating in the global automated CPR devices market include ZOLL Medical Corporation, Stryker, Brunswick MedTech, Michigan Instruments, SunLife Sciences Pvt Ltd., CPR Medical Devices, Inc., Medtronic, Faith Group, Nihon Kohden Corporation, and SCHILLER Americas Inc.